JENNIFER ROCHA: Open Payments
NPI 1821343757 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 24 payments from 10 companies in 2025. Trend: 2023 $115 · 2024 $519 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| Novo Nordisk Inc | 3 | $61 |
| Exact Sciences Corporation | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 1 | $26 |
| ABBVIE INC. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
Products named: TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, Ozempic, JARDIANCE, FARXIGA, Kerendia, AIRSUPRA, SHINGRIX.
Industry payments across CA — which companies pay providers there.
